PLoS ONE 9:e95939
Severe tears requiring surgery represent a different situation where peptides might support post-surgical healing rather than replacing surgical intervention
55,56,57 Recently, the first gene therapy based on clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 technology has been approved for marketing, 58 resulting in revolutionary changes in NADs development
CONTACT Magaly Toro, PhD, MSc, DVM
Synergistic Research Potential of Three Regenerative Peptides The primary advantage of Novera Glow lies not only in the individual properties of its components but also in the opportunity to study them together
Thus, the request for medicinal plants with potential beneficial effects, for MS patients, is constantly increasing